Back to Catalog
Beeline Medicines
beelinemedicines
Precision immunology biotech with five BMS programs and $300M backing.
Total Funding
$300M
sector:biotech
stage:series_a
autoimmune
immunology
lupus
TLR7-TLR8
TYK2
BMS-spinout
Bain-Capital
precision-medicine
clinical-stage
Full Profile Gated
Register as a Qualified Purchaser to access the full profile of Beeline Medicines, including financial analysis, competitive landscape, and investment thesis.